Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Children With Visual Pathway Glioma
NCT00003477Phase 2Completed
- Sponsor
- Burzynski Research Institute
- Start
- Jun 1996
- Primary completion
- May 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in Visual pathway glioma (OPG), sponsored by Burzynski Research Institute. Started Jun 1996; status: completed.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
Visual pathway glioma (OPG)
Beyond the preview
Go deeper on NCT00003477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003477.